Latest Announcements

BSE & NSE corporate filings with AI summaries

NSEGeneral UpdatesResults4d ago

Rossari Biotech Limited

General Updates

Rossari Biotech Limited has announced the outcome of its Board meeting, which approved unaudited financial results for the quarter ended June 30, 2026, grant of options under the Rossari Employee Stock Option Plan - 2019, allotment of equity shares under the same plan, and transfer of 100% shareholding of Rossari International Limited Company to Rossari (Singapore) Pte. Ltd.

Read more →📎 1 attachment
NSEESOP/ESOS/ESPSMgmt Change4d ago

Rossari Biotech Limited

ESOP/ESOS/ESPS

Rossari Biotech Limited has announced the grant of 4000 options under Rossari Employee Stock Option Plan - 2019, allotment of 2500 equity shares, and transfer of 100% shareholding of Rossari International Limited Company to Rossari (Singapore) Pte. Ltd.

Read more →📎 1 attachment
NSECopy of Newspaper PublicationESG4d ago

Alphageo (India) Limited

Copy of Newspaper Publication

Alphageo (India) Limited has informed the Exchange about a copy of newspaper publication regarding the transfer of equity shares to the Investor Education and Protection Fund (IEPF) Account due to unclaimed dividends.

Read more →📎 1 attachment
NSECopy of Newspaper Publication4d ago

Anuh Pharma Limited

Copy of Newspaper Publication

Anuh Pharma Limited has informed the Exchange about the publication of a newspaper advertisement regarding the Notice of the 66th Annual General Meeting, Book Closure, and e-voting information.

Read more →📎 1 attachment
NSEOutcome of Board MeetingFundraise4d ago

Sangam (India) Limited

Outcome of Board Meeting

Sangam (India) Limited has announced the outcome of its board meeting, where it approved the unaudited financial results for the quarter ended June 30, 2026, and the issuance of up to 18,00,000 warrants convertible into equity shares on a preferential basis to the promoter/promoter group at Rs. 555.56 per warrant, aggregating up to Rs. 100,00,08,000. The company also approved a capital expenditure of Rs. 1500 Crores on an expansion project.

Read more →📎 1 attachment
NSECopy of Newspaper PublicationRegulatory4d ago

HCL Technologies Limited

Copy of Newspaper Publication

HCL Technologies Limited has informed the Exchange about Copy of Newspaper Publication, enclosing copies of newspaper advertisements published in English and Hindi newspaper, and making them available on the company's website.

Read more →📎 1 attachment
NSEShareholders meetingMgmt Change4d ago

Shreyans Industries Limited

Shareholders meeting

Shreyans Industries Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 12, 2026, to consider and pass various resolutions, including appointment of a new Chairman & Managing Director, re-appointment of a director, and ratification of the appointment of Cost Auditors.

Read more →📎 1 attachment
NSEAllotment of SecuritiesExpansion4d ago

Rossari Biotech Limited

Allotment of Securities

Rossari Biotech Limited has announced the allotment of 2500 equity shares under the Rossari Employee Stock Option Plan - 2019, and the transfer of 100% shareholding of Rossari International Limited Company to Rossari (Singapore) Pte. Ltd. as part of an internal group restructuring exercise.

Read more →📎 1 attachment
NSEOutcome of Board Meeting▲ PositiveResults4d ago

Sangam (India) Limited

Outcome of Board Meeting

Sangam (India) Limited has submitted its unaudited financial results for the quarter ended June 30, 2026. The company has also announced a preferential issue of up to 18,00,000 warrants convertible into equity shares at a face value of Rs. 10/- per share, aggregating up to Rs. 100,00,08,000/-, to be issued to promoters/promoter group at an issue price of Rs. 555.56/- per warrant. Additionally, the company has approved a capital expenditure of Rs. 1500 Crores (Approx) on an expansion project.

Read more →📎 1 attachment
NSEPress Release▲ PositiveOrder Win4d ago

Natco Pharma Limited

Press Release

Natco Pharma Limited has received tentative approval from the US FDA for its Olaparib tablets, a generic version of AstraZeneca's Lynparza, for the indication in the approved labelling.

Read more →📎 1 attachment
NSEShareholders meeting4d ago

C.E. Info Systems Limited

Shareholders meeting

C.E. Info Systems Limited, also known as MapmyIndia, has announced the notice of its 31st Annual General Meeting (AGM) to be held on August 11, 2026, through video conferencing or other audio-visual means. The meeting will consider the ordinary and special businesses as set out in the notice and the annual report for the financial year 2025-26.

Read more →📎 1 attachment
NSEOutcome of Board MeetingResults4d ago

Rossari Biotech Limited

Outcome of Board Meeting

Rossari Biotech Limited has announced the outcome of its board meeting, which approved unaudited financial results for the quarter ended June 30, 2026, grant of options under the Rossari Employee Stock Option Plan - 2019, allotment of equity shares under the same plan, and transfer of 100% shareholding of Rossari International Limited to Rossari (Singapore) Pte. Ltd.

Read more →📎 1 attachment
NSEGeneral Updates4d ago

Camlin Fine Sciences Limited

General Updates

Camlin Fine Sciences Limited has informed the Exchange about letters sent to Shareholders regarding the Annual Report 2025-26 and the 33rd Annual General Meeting (AGM) scheduled for August 11, 2026.

Read more →📎 1 attachment
NSECopy of Newspaper Publication4d ago

Eveready Industries India Limited

Copy of Newspaper Publication

Eveready Industries India Limited has published a newspaper advertisement regarding the 91st Annual General Meeting, e-Voting Information and Book Closure, as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Read more →📎 1 attachment
NSEShareholders meetingshareholders_meeting4d ago

Camlin Fine Sciences Limited

Shareholders meeting

Camlin Fine Sciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 11, 2026, to consider and adopt audited financial statements for FY 2025-26, re-appointment of directors, and other business.

Read more →📎 1 attachment
← PreviousPage 101 of 830Next →